Bromodomain PHD finger transcription factor (BPTF) is integral to the nucleosome remodeling factor (NURF) complex, a crucial entity in chromatin remodeling and the regulation of gene expression. BPTF distinguishes itself by recognizing and binding to acetylated lysine residues and methylated histones via its bromodomain and PHD fingers, respectively. This unique capability allows BPTF to act as a molecular bridge, facilitating the assembly of the NURF complex at specific genomic regions. The functional outcome of this recruitment is the modulation of chromatin architecture, rendering DNA more or less accessible to transcriptional machinery based on the cellular context and specific signaling cues. BPTF's role is therefore central to a myriad of cellular processes, including but not limited to development, cellular differentiation, and the maintenance of genomic integrity. Through its regulation of gene accessibility and expression, BPTF exerts a profound influence on cell fate decisions and the physiological landscape of the cell.
The activation of BPTF, and consequently the NURF complex, can be orchestrated through various cellular signaling pathways that culminate in the post-translational modifications (PTMs) of BPTF or its associated factors. These modifications, such as acetylation, methylation, and phosphorylation, can enhance BPTF's affinity for chromatin or facilitate its interaction with other proteins within the NURF complex or transcriptional regulators. For instance, specific kinase signaling pathways can lead to the phosphorylation of BPTF, altering its conformation and promoting its recruitment to target genes. Additionally, the acetylation of histones can create binding sites for BPTF's bromodomain, effectively targeting the NURF complex to chromatin regions requiring remodeling. Such activation mechanisms underscore the dynamic nature of chromatin regulation, where BPTF acts not just as a passive participant but as an active mediator of transcriptional responses to internal and external cellular signals. This dynamic interplay between BPTF and the chromatin landscape illustrates the complex regulatory networks governing gene expression and highlights the potential of targeting such epigenetic factors to influence cellular outcomes.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor, it alters chromatin structure, potentially enhancing BPTF-mediated chromatin remodeling. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Another histone deacetylase inhibitor, it affects gene expression and chromatin structure, potentially influencing BPTF activity. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
As a histone deacetylase inhibitor, it can affect chromatin remodeling and gene expression, thereby potentially modulating BPTF function. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
A short-chain fatty acid and histone deacetylase inhibitor, it can modulate gene expression and chromatin structure, affecting BPTF activity. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
A DNA methyltransferase inhibitor, it alters DNA methylation patterns, potentially affecting BPTF-mediated chromatin remodeling. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
A histone deacetylase inhibitor, it can influence chromatin structure and gene expression, thereby potentially affecting BPTF function. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
A histone deacetylase inhibitor, it can alter chromatin structure and gene expression, potentially influencing BPTF activity. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
Inhibits histone deacetylases, potentially affecting BPTF-mediated chromatin remodeling and gene expression. | ||||||
Sirtinol | 410536-97-9 | sc-205976 sc-205976A | 1 mg 5 mg | $38.00 $113.00 | 14 | |
An inhibitor of SIRT1 and SIRT2, it can affect histone acetylation, potentially influencing BPTF activity. | ||||||